炎症蛋白组学对房颤发病预测的价值
年龄性别调整后MIP-1β、HGF、CRP和NT-proBNP与房颤风险升高相关,但进一步调整临床变量后仅NT-proBNP保持显著。结论认为NT-proBNP是房颤强预测因子,炎症细胞因子关联主要由临床危险因素解释且未改善风险预测。
要点
- NT-proBNP是房颤发病的强预测因子,调整临床变量后仍显著。
- MIP-1β、HGF、CRP与房颤的关联在调整临床危险因素后不再显著。
- 炎症细胞因子蛋白组学未改善房颤风险预测。
核心结论
- NT-proBNP是房颤发病的强预测因子。
- 循环炎症细胞因子的关联主要由临床危险因素解释,未改善风险预测。
研究设计与样本
- 采用细胞因子蛋白组学,对46种细胞因子用Cox回归建立房颤发病风险模型。
- 同时分析CRP和NT-proBNP浓度与房颤发病的关联。
主要发现
- 随访期间观察到1246例房颤发病,其中女性占40.5%。
- 性别和年龄调整后,MIP-1β每升高单位HR=1.11(95%CI 1.04,1.17),HGF HR=1.12(95%CI 1.05,1.19),CRP HR=1.17(95%CI 1.10,1.24),NT-proBNP HR=1.58(95%CI 1.45,1.71),均与房颤风险升高相关。
- 进一步调整临床变量后,仅NT-proBNP保持统计学显著。
临床怎么用
- 可将NT-proBNP作为房颤风险评估的参考生物标志物。
- 基于炎症细胞因子蛋白组学筛查房颤风险暂缺乏增量预测价值。
局限性
- 炎症细胞因子在蛋白组学方法中的潜在机制作用尚待进一步阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Atrial fibrillation (AF) has emerged as a common condition in older adults. Cardiovascular risk factors only explain about 50% of AF cases. Inflammatory biomarkers may help close this gap as inflammation can alter atrial electrophysiology and structure. This study aimed to determine a cytokine biomarker profile for this condition in the community using a proteomics approach. METHODS: This study uses cytokine proteomics in participants of the Finnish population-based FINRISK cohort studies 1997/2002. Risk models for 46 cytokines were developed to predict incident AF using Cox regressions. Furthermore, the association of participants' C reactive protein (CRP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) concentrations with incident AF was examined. RESULTS: In 10 744 participants (mean age of 50.9 years, 51.3% women), 1246 cases of incident AF were observed (40.5% women). The main analyses, adjusted for participants' sex and age, suggested that higher concentrations of macrophage inflammatory protein-1β (HR=1.11; 95% CI 1.04, 1.17), hepatocyte growth factor (HR=1.12; 95% CI 1.05, 1.19), CRP (HR=1.17; 95% CI 1.10, 1.24) and NT-proBNP (HR=1.58; 95% CI 1.45, 1.71) were associated with increased risk of incident AF. In further clinical variable-adjusted models, only NT-proBNP remained statistically significant. CONCLUSION: Our study confirmed NT-proBNP as a strong predictor for AF. Observed associations of circulating inflammatory cytokines were primarily explained by clinical risk factors and did not improve risk prediction. The potential mechanistic role of inflammatory cytokines measured in a proteomics approach remains to be further elucidated.
引用
- Börschel CS, Ortega-Alonso A, Havulinna AS, et al. Inflammatory proteomics profiling for prediction of incident atrial fibrillation. Heart. 2023. PMID: 36801832. doi:10.1136/heartjnl-2022-321959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。